Repligen Corporation, a Waltham, Massachusetts-based company, has become a global leader in the development and commercialization of bioprocessing technologies and systems for use in biological drug manufacturing processes. The company offers a range of products, including Protein A ligands, cell culture growth factor products, and chromatography products that are used in the purification of biologics. Repligen Corporation also provides ELISA test kits, chromatography resins, filtration products, process analytics products, and more for laboratory researchers, life sciences companies, biopharmaceutical organizations, and diagnostics companies. The company has collaboration agreements in place with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation has established operations in North America, Europe, the Asia Pacific, and internationally, making it a leading player in the bioprocessing industry.
Repligen's ticker is RGEN
The company's shares trade on the NASDAQ stock exchange
They are based in Waltham, Massachusetts
There are 1001-5000 employees working at Repligen
It is repligen.com/company/about
Repligen is in the Healthcare sector
Repligen is in the Medical Instruments & Supplies industry
The following five companies are Repligen's industry peers: